Target intelligence / Profile preview

Matrin-3 pseudogene (None standard; sometimes LOC401957 in genomic databases)

Target
None standard; sometimes LOC401957 in genomic databases
Molecular classification
Other (Pseudogene)
01

Overview

The *matrin 3 pseudogene* (ENSG00000232952, also known as LOC401957) is a non-functional genomic sequence that resembles the *matrin-3* gene. Pseudogenes arise from gene duplication or retrotransposition but have accumulated mutations that prevent them from encoding a functional protein. Unlike the functional *matrin-3* gene—which is involved in RNA and DNA binding, alternative splicing, and is associated with diseases such as amyotrophic lateral sclerosis—the matrin 3 pseudogene does not produce an active protein and has no established biological function, therapeutic relevance, or disease association. Its presence is mainly cataloged in genomic databases for reference purposes. Key Point: If your focus is therapeutic targeting or disease role, be sure not to confuse the matrin 3 pseudogene with the functional gene (*MATR3*), which is a genuine research and therapeutic interest. The pseudogene itself is not considered a therapeutic target and holds no known biomedical importance.

Other names
LOC401957matrin 3 pseudogene
02

Mechanism of action

None

03

Biological functions

None (pseudogenes do not encode functional protein; some rare pseudogenes can regulate gene expression, but there is no evidence for this pseudogene)
04

Disease associations

None established (pseudogenes are not themselves implicated in disease as functional molecules; the functional matrin-3 gene, not the pseudogene, is implicated in ALS and other diseases)

Beyond the preview

Go deeper on Matrin-3 pseudogene (None standard; sometimes LOC401957 in genomic databases).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Matrin-3 pseudogene (None standard; sometimes LOC401957 in genomic databases).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call